Bio Green Med Solution (BGMS) Share-based Compensation (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Share-based Compensation of $1000.0 for Q1 2026, down 99.94% year-over-year from $1.7 million in Q1 2025, and down 99.85% quarter-over-quarter from $655000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Share-based Compensation (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Share-based Compensation for 17 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 99.94% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $669000.0 (down 67.45% YoY), while the FY2025 annual figure was $2.3 million, up 294.26% from the prior year.
- Share-based Compensation slipped to $1000.0 in Q1 2026 per BGMS's latest filing, from $655000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.7 million in Q1 2025 and bottomed at $1000.0 in Q1 2026.
- Historically, Share-based Compensation has averaged $347352.9 across 5 years, with a median of $350000.0 in 2022.
- Annual changes were most pronounced in 2025 — Share-based Compensation surged 720.69% — and 2026, when it slumped 99.94%.
- Bio Green Med Solution's Share-based Compensation stood at $387000.0 in 2022, then declined by 16.8% to $322000.0 in 2023, then slumped by 71.12% to $93000.0 in 2024, then surged by 604.3% to $655000.0 in 2025, then tumbled by 99.85% to $1000.0 in 2026.
- Business Quant data shows BGMS's Share-based Compensation at $1000.0 in Q1 2026, $655000.0 in Q4 2025, and $6000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.59 Bn | 133.74 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.99 Bn | 59.80 Bn | 1.37 Bn | 4.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.39 Bn | 35.29 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.51 Bn | 32.20 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.07 Bn | 27.24 Bn | - | - |
| 9 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Bio Green Med Solution | 4.95 Mn | 1.16 Mn | 79,000.00 | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 24,937.00 |
| Jun 30, 2025 | 25,106.00 |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 118,989.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 203,000.00 |
| Dec 31, 2023 | 322,000.00 |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 387,000.00 |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 304,000.00 |
| Sep 30, 2021 | 891,015.00 |